Biomea Fusion, Inc

Call
Website
900 Middlefield Rd Ste 4
Redwood City, CA 94063
+1 (650) 980-9099
https://biomeafusion.com

Biomea Fusion, Inc., based in Redwood City, CA, is a clinical-stage biopharmaceutical company dedicated to revolutionizing medicine through the development of novel covalent small molecules aimed at curing serious and life-threatening diseases. The company has established a robust research and development engine that has produced multiple innovative drug programs currently in preclinical and clinical development.

Focused on addressing key mechanisms of disease progression, Biomea's team is involved in all phases of drug discovery and development, including target selection, small molecule design, and clinical studies. Their commitment to creating highly selective targeted medicines positions them at the forefront of therapeutic innovation in diabetes and obesity treatment.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Drugs and drug proprietaries, Vitamin, nutrient, and hematinic preparations for human use

Teva Pharmaceuticals

Teva Pharmaceuticals, based in Redwood City, is dedicated to being a global leader in generics and biopharmaceutical medicines. Their mission is to improve the lives of patients worldwide through their innovative pharmaceutical solutions. Generated from their website's infomation
Services, nec, nec, Vitamin, nutrient, and hematinic preparations for human use

Bolt Biotherapeutics, Inc

Bolt Biotherapeutics is a pioneering biotechnology company based in Redwood City, CA, dedicated to developing targeted immunotherapies that harness the power of the innate and adaptive immune systems to achieve long-term tumor remissions for cancer patients. With a world-class team of fearless innovators, Bolt is at the forefront of a new category of immunotherapies that combine the precision of antibody targeting with the activation of the immune systems within the tumor microenvironment. Their pipeline includes promising candidates such as BDC-1001, a HER2 Boltbody ISAC currently in clinical development for the treatment of HER2 positive colorectal, endometrial, gastroesophageal, and metastatic breast cancer.Generated from the website
Vitamin, nutrient, and hematinic preparations for human use

VIVUS Inc

VIVUS Inc., based in Menlo Park, CA, is committed to improving patient quality of life by addressing the therapeutic needs of individuals with serious medical conditions and life-limiting diseases. With a portfolio that includes PANCREAZE for Exocrine Pancreatic Insufficiency (EPI), the company showcases its expertise in clinical development and commercialization of effective therapies. VIVUS focuses on managing chronic diseases, such as EPI, where patients experience deficiencies in pancreatic enzyme production, leading to severe health issues like malnutrition and weight loss. By providing innovative treatment options, VIVUS aims to enhance the lives of those affected by these debilitating conditions. Generated from the website
United States›California›Redwood City›Biomea Fusion, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.